信诺(CI)
搜索文档
Cigna(CI) - 2024 Q2 - Quarterly Report
2024-08-01 22:34
财务业绩 - 公司总收入同比增长24%,达到117,778百万美元[228] - 调整后收入同比增长24%,达到117,717百万美元[228] - 埃弗纳斯健康服务分部调整后收入同比增长30%,达到95,774百万美元[228] - 医疗保健分部调整后收入同比增长4%,达到26,420百万美元[228] - 调整后每股收益同比增长14%,达到13.19美元[228] - 埃弗纳斯健康服务分部调整后税前利润同比增长5%,达到2,979百万美元[228] - 医疗保健分部调整后税前利润同比增长11%,达到2,544百万美元[228] - 公司股东净利润同比下降53%,为1,271百万美元[228] - 公司三个月和六个月期间的股东净收入分别增长6%和下降53%[238] - 调整后的营业收入分别增长5%和10%,主要由Evernorth Health Services和Cigna Healthcare分部的收益增加带动[239] - 药房收入分别增长33%和32%,主要由于新客户(包括Centene)和内部增长带来的交易量增加[241] - 保费收入分别增长4%和5%,主要由于Cigna Healthcare的保费率上涨,部分被业务结构变化抵消[242] - 费用和其他收入分别增长10%和9%,主要反映了Evernorth Health Services的可负担性改善和业务增长[243] - 投资收益分别增长15%和10%,主要由于平均资产规模增长[244] - 药房和其他服务成本分别增长33%和32%,主要由于新客户(包括Centene)和内部增长带来的交易量增加[245] - 医疗成本和其他福利费用分别增长5%,主要反映了Cigna Healthcare的医疗成本趋势,部分被业务结构变化抵消[246] - 销售、一般和管理费用分别增长7%和6%,主要由于支持业务增长和数字能力提升的战略投资[247] - 公司2024年第二季度和前六个月的调整收入分别增长44%和25%[323] - 公司2024年第二季度和前六个月的税前调整经营(亏损)收益分别下降至(16)百万美元和2百万美元[323,324] - 公司2024年第二季度和前六个月的税前调整利润率分别下降至(7.0)%和0.5%[323] 特殊项目 - 公司确认了一些特殊项目费用,金额为119百万美元[228] - 公司确认了一些净投资损失,金额为1,823百万美元[228] 客户情况 - 医疗客户人数下降2%,主要反映了个人和家庭计划客户的减少[240] - 公司预计2024年67%的Medicare Advantage客户将在四星级或更高的计划中获得奖金支付[251] - 根据更新后的星级评级,公司预计2025年69%的Medicare Advantage客户将在四星级或更高的计划中获得奖金支付[251] - 公司的医疗保险客户总数下降2%,主要由于个人和家庭计划客户的减少[316] 现金流 - 公司2024年上半年经营活动现金流减少,主要由于应收账款增加、2023年6月提前收到的CMS付款缺失以及保险赔付增加所致,部分被新客户带来的现金流正面影响所抵消[259] - 公司2024年上半年投资活动现金流减少,主要由于股票证券购买减少[260] - 公司2024年上半年筹资活动现金流增加,主要由于股票回购增加以及债务融资活动增加[261] 资产负债 - 公司2024年6月30日的债务资本比率为43.6%,较2024年3月31日的44.3%有所下降[267] - 公司2024年2月发行45亿美元新债券,用于回购18亿美元现有债券,剩余资金用于偿还到期债券和一般公司用途[271] - 公司2024年上半年共回购1470万股,总金额约50亿美元,高于2023年同期的380万股和11亿美元[277] - 公司投资资产组合中债券证券、股票证券、商业抵押贷款等资产规模有所下降[329,333,338] - 公司投资组合中约86%为投资级别债券,剩余14%为非投资级别[335] - 公司商业抵押贷款组合信用质量保持良好,但办公楼行业基本面疲弱[341] - 公司其他长期投资中有约4%暴露于办公楼行业[343] - 公司利率上升导致长期债务公允价值下降约19亿美元[347] - 公司股票投资公允价值下降约0.2亿美元[348] 业务表现 - 公司的Pharmacy Benefit Services和Specialty and Care Services收入和营业利润受到交易量、产品组合、价格、合同可负担性服务、专科药品配送客户增长和客户增长等关键因素的影响[291][292][293] - 公司的总收入和毛利润分别增长30%和14%,主要由于Pharmacy Benefit Services和Specialty and Care Services业务的交易量增加[302][303] - 公司的税前调整营业利润增长7%和5%,主要由于Specialty and Care Services业务的增长和可负担性改善,但部分被支持业务增长和能力提升的战略投资所抵消[304] - 公司的调整费用率下降10个和20个基点,主要由于新客户(包括Centene)和有机增长带来的收入增长,部分被支持业务增长和能力提升的战略投资所抵消[305] - 公司预计将于2025年第一季度完成出售Medicare Advantage等业务的交易,交易价值约37亿美元,主要为现金[278]
Cigna (CI) Q2 Earnings and Revenues Beat Estimates
ZACKS· 2024-08-01 20:10
Cigna (CI) came out with quarterly earnings of $6.72 per share, beating the Zacks Consensus Estimate of $6.42 per share. This compares to earnings of $6.13 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 4.67%. A quarter ago, it was expected that this health insurer would post earnings of $6.17 per share when it actually produced earnings of $6.47, delivering a surprise of 4.86%. Over the last four quarters, the company has s ...
Cigna(CI) - 2024 Q2 - Quarterly Results
2024-08-01 18:15
财务业绩 - 总收入同比增长25%至605.23亿美元[9] - 调整后营业利润同比增长5%至19.09亿美元[14] - 2024年全年预计调整后收入至少为2.35亿美元[42] - 2024年全年预计调整后营业利润至少为8.065亿美元[42] - 2024年全年预计调整后每股营业利润至少为28.40美元[42] - 2024年第二季度总收入为605.23亿美元,同比增长24.6%[62] - 2024年第二季度调整后收入为604.7亿美元,同比增长24.4%[62] - 2024年第二季度调整后税前利润为23.72亿美元,同比增长3.4%[62] - 2024年第二季度调整后税后利润为19.09亿美元,同比增长4.9%[62] - 2024年第二季度每股调整后收益为6.72美元,同比增长9.6%[66] 客户数据 - 总医疗客户数为1,904.3万人,主要反映了个人和家庭计划客户的同比下降[21] - 行为健康客户数为2,381.6万人,同比下降主要由于已知的非续约补充行为健康保险合同[22] - 2024年Cigna Healthcare业务预计总医疗客户约1930万[43] 医疗费用 - 医疗保险业务的医疗费用率为82.3%,包括约5000万美元的不利前期收入影响[35] - 医疗保险业务的净医疗费用应付款为50.4亿美元,较上季度下降[36] - 2024年Cigna Healthcare业务预计医疗费用率为81.7%至82.5%[43] 成本管控 - 2024年全年预计调整后销售、一般及管理费用率约为6.1%[42] - 2024年全年预计调整后有效税率为20.5%至21.0%[42] 现金流和股票回购 - 2024年全年预计经营活动现金流至少为11亿美元[42] - 2024年全年预计加权平均股份数为2.82亿至2.86亿股[42] - 截至2024年7月31日,公司已回购1,470万股共计50亿美元[16] 业务分部表现 - 2024年第二季度Evernorth Health Services业务收入和调整后营业利润分别同比增长30%和7%[27] - 2024年第二季度Cigna Healthcare业务收入和调整后营业利润分别同比增长3%[33,34] - 2024年Evernorth业务预计调整后税前营业利润至少为70亿美元[43] - 2024年Cigna Healthcare业务预计调整后税前营业利润至少为47.75亿美元[43] - 2024年第二季度Evernorth Health Services业务调整后税前利润为16.19亿美元,同比增长6.8%[62] - 2024年第二季度Cigna Healthcare业务调整后税前利润为12.04亿美元,同比增长2.7%[62] - 2024年第二季度公司整体调整后税前利润率为3.9%[62] 风险提示 - 上述预测可能存在实际结果与预测不符的风险,公司不承担更新预测的义务[44]
Cigna Profits Hit $1.5 Billion On Pharmacy And Health Services Growth
Forbes· 2024-08-01 18:00
The Cigna Group reported $1.5 billion in second quarter 2024 profits as the diversified provider of ... [+] health insurance and services reaped new clients buying the company's medical and pharmacy benefits. In this photo is The Cigna Group headquarters in Bloomfield, Connecticut, US, on Friday, Oct. 27, 2023. Photographer: Joe Buglewicz/Bloomberg © 2023 Bloomberg Finance LP The Cigna Group reported $1.5 billion in second quarter profits as the diversified provider of medical insurance, pharmacy benefits a ...
The Cigna Group Reports Strong Second Quarter 2024 Results
Prnewswire· 2024-08-01 18:00
文章核心观点 - 公司第二季度总收入同比增长25%至605亿美元 [1] - 公司第二季度调整后营业利润同比增长5%至19亿美元 [1] - 公司预计2024年全年调整后收入至少2350亿美元,调整后每股收益至少28.40美元 [20][21] 关于Evernorth Health Services - Evernorth Health Services第二季度调整后收入和调整后税前营业利润分别同比增长30%和7% [14] - 药品福利服务第二季度调整后收入增长41%,调整后税前营业利润增长3% [14] - 专科和护理服务第二季度调整后收入增长18%,调整后税前营业利润增长12% [14] 关于Cigna Healthcare - Cigna Healthcare第二季度调整后收入同比增长3%,调整后税前营业利润同比增长3% [16] - 医疗保险成本率为82.3%,包括约5000万美元的不利前期收入影响 [16] - 公司预计2024年Cigna Healthcare调整后税前营业利润至少47.75亿美元,医疗保险成本率81.7%-82.5% [23] 关于Corporate and Other Operations - 第二季度调整后税前营业亏损4.51亿美元,主要反映利息费用的影响 [19]
Can Cigna (CI) Beat Q2 Earnings on Growing Pharmacy Revenues?
ZACKS· 2024-07-31 01:51
The Cigna Group (CI) is slated to report second-quarter 2024 results on Aug 1, 2024, before the opening bell.The Zacks Consensus Estimate for Cigna’s second-quarter earnings per share is pegged at $6.42, which indicates growth of 4.7% from the prior-year quarter’s reported figure. The estimate decreased 5 cents in the past 60 days. The consensus mark for revenues is pegged at $58.5 billion, indicating 20.3% growth from the year-ago quarter’s reported number.Image Source: Zacks Investment ResearchCigna boast ...
3 HMO Stocks Set to Thrive on a Varied Customer Base, Tech Investments
ZACKS· 2024-07-25 22:02
The U.S. health insurance industry, commonly referred to as the Health Maintenance Organization (HMO), benefits from a steady membership base through cost-effective plans and numerous contract wins from federal and state authorities. An aging U.S. population boosts the demand for Medicare plans, which insurers leverage to attract seniors and ensure premium flow. Technological advancements, which initially increase expenses, in telehealth enhance care delivery and operational efficiency, reducing healthcare ...
The Cigna Group Foundation Launches Its Health Equity Impact Fund
Prnewswire· 2024-07-22 19:00
Commits $9M in Grants to Reduce Health Disparities beginning with the Houston, TX and Hartford, CT Communities BLOOMFIELD, Conn., July 22, 2024 /PRNewswire/ -- As part of its ongoing commitment to community health and vitality, global health company The Cigna Group (NYSE: CI) today announced the creation of The Cigna Group Health Equity Impact Fund, a community program in which The Cigna Group Foundation will commit $9 million over three years to reduce key health barriers by specifically targeting health d ...
The Cigna Group Foundation Launches Its Health Equity Impact Fund
Prnewswire· 2024-07-22 19:00
Commits $9M in Grants to Reduce Health Disparities beginning with the Houston, TX and Hartford, CT CommunitiesBLOOMFIELD, Conn., July 22, 2024 /PRNewswire/ -- As part of its ongoing commitment to community health and vitality, global health company The Cigna Group (NYSE: CI) today announced the creation of The Cigna Group Health Equity Impact Fund, a community program in which The Cigna Group Foundation will commit $9 million over three years to reduce key health barriers by specifically targeting health di ...
4 Healthcare Stocks Poised to Beat Q2 Earnings Estimates
ZACKS· 2024-07-19 23:41
The second-quarter 2024 earnings season for healthcare stocks is in full swing now. Per early reports, rising patient volumes, revenue per patient days, utilization, premium rate hikes coupled with rising demand for affordable healthcare plans and technological enhancements have led to growth in healthcare stocks, which is part of the broader Zacks Medical sector (one of the 16 broad Zacks sectors within the Zacks Industry).While there were positives, increasing expenses due to increased utilization partly ...